The Scrip 100: Changes At The Top Of The Leaderboard
Pfizer continued its reign as the Scrip 100 leader for a third year, while Lilly and Novo climbed higher.
Pfizer continued its reign as the Scrip 100 leader for a third year, while Lilly and Novo climbed higher.